Omega Healthcare Investors (NYSE:OHI) Given New $45.00 Price Target at BMO Capital Markets

Omega Healthcare Investors (NYSE:OHI - Free Report) had its target price raised by BMO Capital Markets from $44.00 to $45.00 in a report released on Monday morning, Benzinga reports. They currently have a market perform rating on the real estate investment trust's stock.

Other research analysts also recently issued reports about the stock. Scotiabank lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a sector perform rating in a research note on Monday, August 26th. Mizuho downgraded shares of Omega Healthcare Investors from an outperform rating to a neutral rating and lifted their target price for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Truist Financial boosted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a hold rating in a research report on Wednesday, September 4th. Finally, Wells Fargo & Company reissued an overweight rating and set a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Eight equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Hold and a consensus price target of $37.00.

Omega Healthcare Investors Trading Up 0.4 %

Shares of OHI traded up $0.14 during mid-day trading on Monday, reaching $39.49. The company's stock had a trading volume of 1,077,683 shares, compared to its average volume of 1,682,136. The stock has a market cap of $10.18 billion, a PE ratio of 35.59, a P/E/G ratio of 1.29 and a beta of 1.00. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors has a 52 week low of $27.53 and a 52 week high of $41.53. The company's fifty day moving average price is $39.10 and its two-hundred day moving average price is $34.66.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.65 by ($0.20). The business had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The company's revenue was up 17.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.74 earnings per share. On average, analysts predict that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.79%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors's dividend payout ratio is presently 241.44%.

Insider Transactions at Omega Healthcare Investors

In other news, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company's stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, COO Daniel J. Booth sold 56,725 shares of the company's stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Robert O. Stephenson sold 22,542 shares of the company's stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.37% of the company's stock.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of hedge funds have recently bought and sold shares of OHI. Versant Capital Management Inc bought a new position in Omega Healthcare Investors during the 2nd quarter valued at about $26,000. WFA Asset Management Corp bought a new position in Omega Healthcare Investors during the 1st quarter valued at about $39,000. Covestor Ltd lifted its stake in Omega Healthcare Investors by 47.6% during the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust's stock valued at $42,000 after acquiring an additional 431 shares during the period. Highlander Capital Management LLC lifted its stake in Omega Healthcare Investors by 52.0% during the 1st quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust's stock valued at $60,000 after acquiring an additional 650 shares during the period. Finally, GAMMA Investing LLC lifted its stake in Omega Healthcare Investors by 93.4% during the 2nd quarter. GAMMA Investing LLC now owns 2,446 shares of the real estate investment trust's stock valued at $84,000 after acquiring an additional 1,181 shares during the period. Institutional investors own 65.25% of the company's stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.